- Report
- November 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
From €3327EUR$3,500USD£2,795GBP
The Implantable Cardiac Rhythm Management Device (CRM) market is a subset of the larger Cardiovascular Devices market. CRM devices are used to monitor and treat cardiac arrhythmias, or abnormal heart rhythms. These devices are implanted in the body and can detect and treat arrhythmias, as well as provide data to physicians for diagnosis and treatment. CRM devices include pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.
CRM devices are used to treat a variety of cardiac conditions, including bradycardia, tachycardia, and atrial fibrillation. They are also used to monitor heart rate and rhythm, and to provide data to physicians for diagnosis and treatment.
Some of the major companies in the Implantable Cardiac Rhythm Management Device market include Medtronic, Abbott, Boston Scientific, Biotronik, and Sorin Group. Show Less Read more